Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort.

Bohers E, Viailly PJ, Becker S, Marchand V, Ruminy P, Maingonnat C, Bertrand P, Etancelin P, Picquenot JM, Camus V, Menard AL, Lemasle E, Contentin N, Leprêtre S, Lenain P, Stamatoullas A, Lanic H, Libraire J, Vaudaux S, Pepin LF, Vera P, Tilly H, Jardin F.

Blood Cancer J. 2018 Aug 1;8(8):74. doi: 10.1038/s41408-018-0111-6.

2.

Somatic mutations of cell-free circulating DNA detected by targeted next-generation sequencing and digital droplet PCR in classical Hodgkin lymphoma.

Bessi L, Viailly PJ, Bohers E, Ruminy P, Maingonnat C, Bertrand P, Vasseur N, Beaussire L, Cornic M, Etancelin P, Camus V, Picquenot JM, Tilly H, Stamatoullas A, Jardin F.

Leuk Lymphoma. 2019 Feb;60(2):498-502. doi: 10.1080/10428194.2018.1492123. Epub 2018 Aug 2. No abstract available.

PMID:
30068243
3.

New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes.

Maitre E, Bertrand P, Maingonnat C, Viailly PJ, Wiber M, Naguib D, Salaün V, Cornet E, Damaj G, Sola B, Jardin F, Troussard X.

Oncotarget. 2018 Jun 22;9(48):28866-28876. doi: 10.18632/oncotarget.25601. eCollection 2018 Jun 22.

4.

Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.

Fontanilles M, Marguet F, Bohers É, Viailly PJ, Dubois S, Bertrand P, Camus V, Mareschal S, Ruminy P, Maingonnat C, Lepretre S, Veresezan EL, Derrey S, Tilly H, Picquenot JM, Laquerrière A, Jardin F.

Oncotarget. 2017 Jul 18;8(29):48157-48168. doi: 10.18632/oncotarget.18325.

5.

Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing.

Mareschal S, Pham-Ledard A, Viailly PJ, Dubois S, Bertrand P, Maingonnat C, Fontanilles M, Bohers E, Ruminy P, Tournier I, Courville P, Lenormand B, Duval AB, Andrieu E, Verneuil L, Vergier B, Tilly H, Joly P, Frebourg T, Beylot-Barry M, Merlio JP, Jardin F.

J Invest Dermatol. 2017 Sep;137(9):1984-1994. doi: 10.1016/j.jid.2017.04.010. Epub 2017 May 4.

6.

Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases.

Dubois S, Viailly PJ, Bohers E, Bertrand P, Ruminy P, Marchand V, Maingonnat C, Mareschal S, Picquenot JM, Penther D, Jais JP, Tesson B, Peyrouze P, Figeac M, Desmots F, Fest T, Haioun C, Lamy T, Copie-Bergman C, Fabiani B, Delarue R, Peyrade F, André M, Ketterer N, Leroy K, Salles G, Molina TJ, Tilly H, Jardin F.

Clin Cancer Res. 2017 May 1;23(9):2232-2244. doi: 10.1158/1078-0432.CCR-16-1922. Epub 2016 Dec 6.

7.

Oncogenic events rather than antigen selection pressure may be the main driving forces for relapse in diffuse large B-cell lymphomas.

Rizzo D, Viailly PJ, Mareschal S, Bohers E, Picquenot JM, Penther D, Dubois S, Marchand V, Bertrand P, Maingonnat C, Etancelin P, Feuillard J, Bastard C, Tilly H, Jardin F, Ruminy P.

Am J Hematol. 2017 Jan;92(1):68-76. doi: 10.1002/ajh.24584.

8.

Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma.

Camus V, Stamatoullas A, Mareschal S, Viailly PJ, Sarafan-Vasseur N, Bohers E, Dubois S, Picquenot JM, Ruminy P, Maingonnat C, Bertrand P, Cornic M, Tallon-Simon V, Becker S, Veresezan L, Frebourg T, Vera P, Bastard C, Tilly H, Jardin F.

Haematologica. 2016 Sep;101(9):1094-101. doi: 10.3324/haematol.2016.145102. Epub 2016 Jun 13.

9.

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.

Jardin F, Pujals A, Pelletier L, Bohers E, Camus V, Mareschal S, Dubois S, Sola B, Ochmann M, Lemonnier F, Viailly PJ, Bertrand P, Maingonnat C, Traverse-Glehen A, Gaulard P, Damotte D, Delarue R, Haioun C, Argueta C, Landesman Y, Salles G, Jais JP, Figeac M, Copie-Bergman C, Molina TJ, Picquenot JM, Cornic M, Fest T, Milpied N, Lemasle E, Stamatoullas A, Moeller P, Dyer MJ, Sundstrom C, Bastard C, Tilly H, Leroy K.

Am J Hematol. 2016 Sep;91(9):923-30. doi: 10.1002/ajh.24451. Epub 2016 Jul 4.

10.

HACE1 is a putative tumor suppressor gene in B-cell lymphomagenesis and is down-regulated by both deletion and epigenetic alterations.

Bouzelfen A, Alcantara M, Kora H, Picquenot JM, Bertrand P, Cornic M, Mareschal S, Bohers E, Maingonnat C, Ruminy P, Adriouch S, Boyer O, Dubois S, Bastard C, Tilly H, Latouche JB, Jardin F.

Leuk Res. 2016 Jun;45:90-100. doi: 10.1016/j.leukres.2016.04.007. Epub 2016 Apr 11.

PMID:
27107267
11.

Digital PCR for quantification of recurrent and potentially actionable somatic mutations in circulating free DNA from patients with diffuse large B-cell lymphoma.

Camus V, Sarafan-Vasseur N, Bohers E, Dubois S, Mareschal S, Bertrand P, Viailly PJ, Ruminy P, Maingonnat C, Lemasle E, Stamatoullas A, Picquenot JM, Cornic M, Beaussire L, Bastard C, Frebourg T, Tilly H, Jardin F.

Leuk Lymphoma. 2016 Sep;57(9):2171-9. doi: 10.3109/10428194.2016.1139703. Epub 2016 Feb 17.

PMID:
26883583
12.

Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study.

Dubois S, Viailly PJ, Mareschal S, Bohers E, Bertrand P, Ruminy P, Maingonnat C, Jais JP, Peyrouze P, Figeac M, Molina TJ, Desmots F, Fest T, Haioun C, Lamy T, Copie-Bergman C, Brière J, Petrella T, Canioni D, Fabiani B, Coiffier B, Delarue R, Peyrade F, Bosly A, André M, Ketterer N, Salles G, Tilly H, Leroy K, Jardin F.

Clin Cancer Res. 2016 Jun 15;22(12):2919-28. doi: 10.1158/1078-0432.CCR-15-2305. Epub 2016 Jan 27.

13.

Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma.

Mareschal S, Dubois S, Viailly PJ, Bertrand P, Bohers E, Maingonnat C, Jaïs JP, Tesson B, Ruminy P, Peyrouze P, Copie-Bergman C, Fest T, Jo Molina T, Haioun C, Salles G, Tilly H, Lecroq T, Leroy K, Jardin F.

Genes Chromosomes Cancer. 2016 Mar;55(3):251-67. doi: 10.1002/gcc.22328. Epub 2015 Nov 26.

PMID:
26608593
14.

Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: implications for targeted EZH2 inhibitor therapy?

Dubois S, Mareschal S, Picquenot JM, Viailly PJ, Bohers E, Cornic M, Bertrand P, Veresezan EL, Ruminy P, Maingonnat C, Marchand V, Lanic H, Penther D, Bastard C, Tilly H, Jardin F.

Oncotarget. 2015 Jun 30;6(18):16712-24.

15.

Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis.

Bohers E, Viailly PJ, Dubois S, Bertrand P, Maingonnat C, Mareschal S, Ruminy P, Picquenot JM, Bastard C, Desmots F, Fest T, Leroy K, Tilly H, Jardin F.

Haematologica. 2015 Jul;100(7):e280-4. doi: 10.3324/haematol.2015.123612. Epub 2015 Mar 6. No abstract available.

16.

CD70: A Potential Target in Breast Cancer?

Petrau C, Cornic M, Bertrand P, Maingonnat C, Marchand V, Picquenot JM, Jardin F, Clatot F.

J Cancer. 2014 Oct 22;5(9):761-4. doi: 10.7150/jca.10360. eCollection 2014.

17.

Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine era.

Bohers E, Mareschal S, Bertrand P, Viailly PJ, Dubois S, Maingonnat C, Ruminy P, Tilly H, Jardin F.

Leuk Lymphoma. 2015 May;56(5):1213-22. doi: 10.3109/10428194.2014.941836. Epub 2014 Oct 9. Review.

PMID:
25130477
18.

Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphoma.

Bohers E, Mareschal S, Bouzelfen A, Marchand V, Ruminy P, Maingonnat C, Ménard AL, Etancelin P, Bertrand P, Dubois S, Alcantara M, Bastard C, Tilly H, Jardin F.

Genes Chromosomes Cancer. 2014 Feb;53(2):144-53. doi: 10.1002/gcc.22126. Epub 2013 Nov 5.

PMID:
24327543
19.

The costimulatory molecule CD70 is regulated by distinct molecular mechanisms and is associated with overall survival in diffuse large B-cell lymphoma.

Bertrand P, Maingonnat C, Penther D, Guney S, Ruminy P, Picquenot JM, Mareschal S, Alcantara M, Bouzelfen A, Dubois S, Figeac M, Bastard C, Tilly H, Jardin F.

Genes Chromosomes Cancer. 2013 Aug;52(8):764-74. doi: 10.1002/gcc.22072. Epub 2013 May 28.

PMID:
23716461
20.

Interim positron emission tomography scan associated with international prognostic index and germinal center B cell-like signature as prognostic index in diffuse large B-cell lymphoma.

Lanic H, Mareschal S, Mechken F, Picquenot JM, Cornic M, Maingonnat C, Bertrand P, Clatot F, Bohers E, Stamatoullas A, Leprêtre S, Rainville V, Ruminy P, Bastard C, Tilly H, Becker S, Vera P, Jardin F.

Leuk Lymphoma. 2012 Jan;53(1):34-42. doi: 10.3109/10428194.2011.600482. Epub 2011 Aug 1.

PMID:
21806349
21.

Comment to: The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica 2007; 92:1335-1342.

Bertrand P, Maingonnat C, Ruminy P, Tilly H, Bastard C.

Haematologica. 2008 Jul;93(7):e53; author reply e54. doi: 10.3324/haematol.13190. No abstract available.

22.

Characterization of three t(3;8)(q27;q24) translocations from diffuse large B-cell lymphomas.

Bertrand P, Maingonnat C, Picquenot JM, Dastugue N, Penther D, Ysebaert L, Maisonneuve C, Tilly H, Bastard C.

Leukemia. 2008 May;22(5):1064-7. Epub 2007 Nov 8. No abstract available.

PMID:
17989722
23.

PVRL2 is translocated to the TRA@ locus in t(14;19)(q11;q13)-positive peripheral T-cell lymphomas.

Almire C, Bertrand P, Ruminy P, Maingonnat C, Wlodarska I, Martín-Subero JI, Siebert R, Tilly H, Bastard C.

Genes Chromosomes Cancer. 2007 Nov;46(11):1011-8.

PMID:
17696193
24.

Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.

Bertrand P, Bastard C, Maingonnat C, Jardin F, Maisonneuve C, Courel MN, Ruminy P, Picquenot JM, Tilly H.

Leukemia. 2007 Mar;21(3):515-23. Epub 2007 Jan 18.

PMID:
17230227
25.

Hyaluronectin modulation of lung metastasis in nude mice.

Paris S, Sesboüé R, Chauzy C, Maingonnat C, Delpech B.

Eur J Cancer. 2006 Dec;42(18):3253-9. Epub 2006 Aug 23.

PMID:
16930992
26.

Expression of HYAL2 mRNA, hyaluronan and hyaluronidase in B-cell non-Hodgkin lymphoma: relationship with tumor aggressiveness.

Bertrand P, Courel MN, Maingonnat C, Jardin F, Tilly H, Bastard C.

Int J Cancer. 2005 Jan 10;113(2):207-12.

27.

Biodistribution of injected tritiated hyaluronic acid in mice: a comparison between macromolecules and hyaluronic acid-derived oligosaccharides.

Courel MN, Maingonnat C, Bertrand P, Chauzy C, Smadja-Joffe F, Delpech B.

In Vivo. 2004 Mar-Apr;18(2):181-7.

28.

Hyaluronidase in sera of tumour-bearing nude mice.

Maingonnat C, Courel MN, Bertrand P, Vincent JC, Sesboüé R, Delpech B.

Biomarkers. 2003 May-Aug;8(3-4):333-8.

PMID:
12944181
29.

Human monocytes synthesize hyaluronidase.

Girard N, Maingonnat C, Bertrand P, Tilly H, Vannier JP, Delpech B.

Br J Haematol. 2002 Oct;119(1):199-203.

PMID:
12358926
30.

Hyaluronidase is more elevated in human brain metastases than in primary brain tumours.

Delpech B, Laquerriere A, Maingonnat C, Bertrand P, Freger P.

Anticancer Res. 2002 Jul-Aug;22(4):2423-7.

PMID:
12174938
31.

Hyaluronan digestion and synthesis in an experimental model of metastatic tumour.

Delpech B, Courel MN, Maingonnat C, Chauzy C, Sesboüé R, Pratesi G.

Histochem J. 2001 Sep-Oct;33(9-10):553-8.

PMID:
12005027
32.

Importance of hyaluronan length in a hyaladherin-based assay for hyaluronan.

Courel MN, Maingonnat C, Tranchepain F, Deschrevel B, Vincent JC, Bertrand P, Delpech B.

Anal Biochem. 2002 Mar 15;302(2):285-90.

PMID:
11878809
33.

Hyaluronectin secretion by monocytes: downregulation by IL-4 and IL-13, upregulation by IL-10.

Girard N, Maingonnat C, Bertrand P, Vasse M, Delpech B.

Cytokine. 1999 Aug;11(8):579-84.

PMID:
10433804
34.

Activation and inhibition of human cancer cell hyaluronidase by proteins.

Maingonnat C, Victor R, Bertrand P, Courel MN, Maunoury R, Delpech B.

Anal Biochem. 1999 Mar 1;268(1):30-4.

PMID:
10036158
35.

[Production of hyaluronidase by cultured human tumor cells].

Victor R, Maingonnat C, Chauzy C, Bertrand P, Olivier A, Maunoury R, Gioanni J, Delpech B.

C R Acad Sci III. 1997 Oct;320(10):805-10. French.

PMID:
9436534
36.

The origin of hyaluronectin in human tumors.

Delpech B, Girard N, Olivier A, Maingonnat C, van Driessche G, van Beeumen J, Bertrand P, Duval C, Delpech A, Bourguignon J.

Int J Cancer. 1997 Sep 17;72(6):942-8.

37.

Hyaluronan and hyaluronectin production in injured rat thoracic aorta.

Chajara A, Levesque H, Courel MN, Chauzy C, Maingonnat C, Bertrand P, Delpech B.

Atherosclerosis. 1996 Sep 6;125(2):193-207.

PMID:
8842351
38.

Enzyme-linked hyaluronectin: a unique reagent for hyaluronan assay and tissue location and for hyaluronidase activity detection.

Delpech B, Bertrand P, Maingonnat C, Girard N, Chauzy C.

Anal Biochem. 1995 Jul 20;229(1):35-41.

PMID:
8533892
39.

Expression and effects of hyaluronan and of the hyaluronan-binding protein hyaluronectin in newborn rat brain glial cell cultures.

Marret S, Delpech B, Delpech A, Asou H, Girard N, Courel MN, Chauzy C, Maingonnat C, Fessard C.

J Neurochem. 1994 Apr;62(4):1285-95.

PMID:
7510775
40.

Localization and solubilization of hyaluronan and of the hyaluronan-binding protein hyaluronectin in human normal and arteriosclerotic arterial walls.

Lévesque H, Girard N, Maingonnat C, Delpech A, Chauzy C, Tayot J, Courtois H, Delpech B.

Atherosclerosis. 1994 Jan;105(1):51-62.

PMID:
7512338
41.

Caffeine decreases glial cell number and increases hyaluronan secretion in newborn rat brain cultures.

Marret S, Delpech B, Girard N, Leroy A, Maingonnat C, Menard JF, Fessard C.

Pediatr Res. 1993 Dec;34(6):716-9.

PMID:
8108181
42.

Hyaluronan and hyaluronectin in the extracellular matrix of human brain tumour stroma.

Delpech B, Maingonnat C, Girard N, Chauzy C, Maunoury R, Olivier A, Tayot J, Creissard P.

Eur J Cancer. 1993;29A(7):1012-7.

PMID:
7684596
43.

Establishment and characterisation of a human glioma cell line.

Chauzy C, Delpech B, Olivier A, Bastard C, Girard N, Courel MN, Maingonnat C, Frébourg T, Tayot J, Creissard P.

Eur J Cancer. 1992;28A(6-7):1129-34.

PMID:
1378293
44.

Enzyme immunoassay of hyaluronic acid in serum and pleural fluid using sheep brain hyaluronectin.

Maingonnat C, Delpech B.

Ann Clin Biochem. 1991 May;28 ( Pt 3):305-6. No abstract available.

PMID:
1714687
45.

Characterization of a hyaluronic acid-binding protein from sheep brain comparison with human brain hyaluronectin.

Delpech B, Maingonnat C, Delpech A, Maes P, Girard N, Bertrand P.

Int J Biochem. 1991;23(3):329-37.

PMID:
1710584
46.

Serum hyaluronan (hyaluronic acid) in breast cancer patients.

Delpech B, Chevallier B, Reinhardt N, Julien JP, Duval C, Maingonnat C, Bastit P, Asselain B.

Int J Cancer. 1990 Sep 15;46(3):388-90.

PMID:
2394505
47.

The quantitation of pleural hyaluronic acid by an immunoenzymoassay.

Bertrand J, Delpech B, Maingonnat C, Bertrand P, Picard J.

Ann Clin Biochem. 1990 Mar;27 ( Pt 2):167-8. No abstract available.

PMID:
2183691
48.

[Nyctohemeral changes of the blood level of hyaluronic acid in rheumatoid arthritis].

Chassagne P, Le Loet X, Delpech B, Levesque H, Menard JF, Maingonnat C, Deshayes P.

Rev Rhum Mal Osteoartic. 1989 Nov;56(11):775-9. French. No abstract available.

PMID:
2692135
49.

Hyaluronan and hyaluronectin in the nervous system.

Delpech B, Delpech A, Brückner G, Girard N, Maingonnat C.

Ciba Found Symp. 1989;143:208-20; discussion 221-32, 281-5. Review.

PMID:
2478345
50.

Hyaluronectin: detection with monoclonal antibodies in human tumors.

Girard N, Courel MN, Maingonnat C, Delpech B.

Hybridoma. 1988 Aug;7(4):333-40.

PMID:
2459045

Supplemental Content

Loading ...
Support Center